Published in Ann Thorac Surg on September 01, 2003
[18F]FLT-PET in oncology: current status and opportunities. Eur J Nucl Med Mol Imaging (2004) 1.61
18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity. Eur J Nucl Med Mol Imaging (2009) 1.06
Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study. Thorax (2007) 1.05
The role of positron emission tomography in the management of non-small cell lung cancer. Can J Surg (2009) 0.86
Diagnostic performance of (18)F-FDG PET/CT for lymph node staging in patients with operable non-small-cell lung cancer and inflammatory lung disease. Lung (2008) 0.83
The maximum standardized FDG uptake on PET-CT in patients with non-small cell lung cancer. Multidiscip Respir Med (2013) 0.83
Characteristics of Metastatic Mediastinal Lymph Nodes of Non-Small Cell Lung Cancer on Preoperative F-18 FDG PET/CT. Nucl Med Mol Imaging (2013) 0.82
Relapse in resected lung cancer revisited: does intensified follow up really matter? A prospective study. World J Surg Oncol (2009) 0.82
Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer. Ann Nucl Med (2015) 0.79
Clinical significance of preoperative carcinoembryonic antigen level in patients with clinical stage IA non-small cell lung cancer. J Thorac Dis (2017) 0.78
Sampling versus systematic full lymphatic dissection in surgical treatment of non-small cell lung cancer. Oncol Rev (2013) 0.75
Diagnosis, staging and treatment of patients with non-small cell lung cancer for the surgeon. Indian J Surg (2010) 0.75
FDG-PET parameters predicting mediastinal malignancy in lung cancer. BMC Pulm Med (2016) 0.75
Unusual False-Positive Mesenteric Lymph Nodes Detected by PET/CT in a Metastatic Survey of Lung Cancer. Case Rep Gastroenterol (2016) 0.75
Initial consecutive experience of completely portal robotic pulmonary resection with 4 arms. J Thorac Cardiovasc Surg (2011) 2.81
Intercostal muscle flap reduces the pain of thoracotomy: a prospective randomized trial. J Thorac Cardiovasc Surg (2005) 2.45
Results of a prospective algorithm to remove chest tubes after pulmonary resection with high output. J Thorac Cardiovasc Surg (2008) 2.39
The Society of Thoracic Surgeons expert consensus for the surgical treatment of hyperhidrosis. Ann Thorac Surg (2011) 2.38
Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. J Thorac Cardiovasc Surg (2006) 2.31
Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer. Ann Thorac Surg (2006) 2.02
Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry. Ann Thorac Surg (2012) 1.99
Intracostal sutures decrease the pain of thoracotomy. Ann Thorac Surg (2003) 1.97
Starting a robotic program in general thoracic surgery: why, how, and lessons learned. Ann Thorac Surg (2011) 1.84
Daily chest roentgenograms are unnecessary in nonhypoxic patients who have undergone pulmonary resection by thoracotomy. Ann Thorac Surg (2011) 1.72
The true false negative rates of esophageal and endobronchial ultrasound in the staging of mediastinal lymph nodes in patients with non-small cell lung cancer. Ann Thorac Surg (2010) 1.69
The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg (2005) 1.63
The removal of chest tubes despite an air leak or a pneumothorax. Ann Thorac Surg (2009) 1.62
Management of subcutaneous emphysema after pulmonary resection. Ann Thorac Surg (2008) 1.59
Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications. Ann Thorac Surg (2009) 1.56
The treatment of patients with stage IIIA non-small cell lung cancer from N2 disease: who returns to the surgical arena and who survives. Ann Thorac Surg (2008) 1.56
Management of thoracic esophageal perforations. Eur J Cardiothorac Surg (2011) 1.50
Functional imaging: II. Prediction of epilepsy surgery outcome. Ann Neurol (2008) 1.48
The benefits of continuous and digital air leak assessment after elective pulmonary resection: a prospective study. Ann Thorac Surg (2008) 1.46
How to teach robotic pulmonary resection. Semin Thorac Cardiovasc Surg (2013) 1.38
Promise and pitfalls of quantitative imaging in oncology clinical trials. Magn Reson Imaging (2012) 1.34
Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans. Ann Thorac Surg (2005) 1.33
Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer. Ann Thorac Surg (2004) 1.30
Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men. Chest (2006) 1.27
The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg (2004) 1.24
Functional imaging: I. Relative predictive value of intracranial electroencephalography. Ann Neurol (2008) 1.20
Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer. Ann Thorac Surg (2008) 1.18
Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal (N2) lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with nonsmall-cell lung cancer. Ann Thorac Surg (2007) 1.18
Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial. Int J Radiat Oncol Biol Phys (2009) 1.17
Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches. Neuroimage (2013) 1.17
Efficacy of video-assisted thoracoscopic surgery with talc pleurodesis for porous diaphragm syndrome in patients with refractory hepatic hydrothorax. Ann Thorac Surg (2006) 1.17
Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial. Ann Thorac Surg (2005) 1.17
A nondivided intercostal muscle flap further reduces pain of thoracotomy: a prospective randomized trial. Ann Thorac Surg (2008) 1.16
Effect of sympathectomy level on the incidence of compensatory hyperhidrosis after sympathectomy for palmar hyperhidrosis. J Thorac Cardiovasc Surg (2009) 1.12
Fast tracking after Ivor Lewis esophagogastrectomy. Chest (2004) 1.11
Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival. Ann Thorac Surg (2006) 1.11
Survival and outcomes of pulmonary resection for non-small cell lung cancer in the elderly: a nested case-control study. Ann Thorac Surg (2006) 1.08
Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation. Nucl Med Commun (2009) 1.05
Brain tumors. Semin Nucl Med (2012) 1.05
Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanisms. J Clin Oncol (2009) 1.04
Distribution and likelihood of lymph node metastasis based on the lobar location of nonsmall-cell lung cancer. Ann Thorac Surg (2006) 1.03
Surgical techniques and results for partial or circumferential sleeve resection of the pulmonary artery for patients with non-small cell lung cancer. Ann Thorac Surg (2007) 1.03
A prospective study to determine the incidence of non-imaged malignant pulmonary nodules in patients who undergo metastasectomy by thoracotomy with lung palpation. Ann Thorac Surg (2011) 1.03
Rigid bronchoscopy and surgical resection for broncholithiasis and calcified mediastinal lymph nodes. J Thorac Cardiovasc Surg (2008) 1.02
Non-imaged pulmonary nodules discovered during thoracotomy for metastasectomy by lung palpation. Eur J Cardiothorac Surg (2009) 1.00
Ictal SPECT analysis in epilepsy: subtraction and statistical parametric mapping techniques. Neurology (2004) 1.00
Functional assessment of pulmonary vein stenosis using radionuclide ventilation/perfusion imaging. Chest (2004) 0.99
The predictive value of creatine phosphokinase and alkaline phosphatase in identification of heterotopic ossification in patients after spinal cord injury. Arch Phys Med Rehabil (2003) 0.99
The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg (2005) 0.99
Informatics methods to enable sharing of quantitative imaging research data. Magn Reson Imaging (2012) 0.99
Accessing the aortopulmonary window (#5) and the paraaortic (#6) lymph nodes in patients with non-small cell lung cancer. Ann Thorac Surg (2007) 0.98
Operative techniques in robotic thoracic surgery for inferior or posterior mediastinal pathology. J Thorac Cardiovasc Surg (2012) 0.97
General thoracic surgery is safe in patients taking clopidogrel (Plavix). J Thorac Cardiovasc Surg (2010) 0.95
Is botulinum toxin injection of the pylorus during Ivor Lewis [corrected] esophagogastrectomy the optimal drainage strategy? J Thorac Cardiovasc Surg (2009) 0.94
Localization of parathyroid adenomas by sonography and technetium tc 99m sestamibi single-photon emission computed tomography before minimally invasive parathyroidectomy: are both studies really needed? J Ultrasound Med (2009) 0.94
Pulmonary resection after concurrent chemotherapy and high dose (60Gy) radiation for non-small cell lung cancer is safe and may provide increased survival. Eur J Cardiothorac Surg (2009) 0.94
Technical aspects and early results of robotic esophagectomy with chest anastomosis. J Thorac Cardiovasc Surg (2012) 0.93
18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer. J Nucl Med (2007) 0.93
Complete thoracic mediastinal lymphadenectomy leads to a higher rate of pathologically proven N2 disease in patients with non-small cell lung cancer. Ann Thorac Surg (2012) 0.91
Is palpation of the nonresected pulmonary lobe(s) required for patients with non-small cell lung cancer? A prospective study. J Thorac Cardiovasc Surg (2008) 0.91
Minimally invasive chest wall resection: sparing the overlying, uninvolved extrathoracic musculature of the chest. Ann Thorac Surg (2012) 0.90
Survival of patients with true pathologic stage I non-small cell lung cancer. Ann Thorac Surg (2009) 0.90
Thoracoscopic and robotic dissection of mediastinal lymph nodes. Thorac Surg Clin (2012) 0.89
Improved Benefit of SPECT/CT Compared to SPECT Alone for the Accurate Localization of Endocrine and Neuroendocrine Tumors. Mol Imaging Radionucl Ther (2012) 0.89
Regional cerebral blood flow and magnetic resonance spectroscopic imaging findings in diaschisis from stroke. Stroke (2002) 0.89
The management of chest tubes in patients with a pneumothorax and an air leak after pulmonary resection. Chest (2005) 0.89
Video-assisted thoracoscopic surgery using single-lumen endotracheal tube anesthesia. Chest (2004) 0.88
Different diffusing capacity of the lung for carbon monoxide as predictors of respiratory morbidity. Ann Thorac Surg (2009) 0.88
Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis. Antimicrob Agents Chemother (2013) 0.87
Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma. J Thorac Cardiovasc Surg (2003) 0.86
Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro-deoxyglucose positron emission tomography for assessment of brain tumor progression. J Neuroimaging (2010) 0.85
The management of chest tubes after pulmonary resection. Thorac Surg Clin (2010) 0.85
Pulmonary resection after high-dose and low-dose chest irradiation. Ann Thorac Surg (2005) 0.84
Optimal care of patients with non-small cell lung cancer reduces perioperative morbidity. J Thorac Cardiovasc Surg (2010) 0.83
F-18 FDG brain positron emission tomography and Tl-201 early and delayed SPECT in distinguishing atypical cerebral tumor from cerebral infarction. Clin Nucl Med (2003) 0.83
SPECT Imaging of Epilepsy: An Overview and Comparison with F-18 FDG PET. Int J Mol Imaging (2011) 0.83
18F-FDG positron emission tomography CT (FDG PET-CT) in the management of pancreatic cancer: initial experience in 12 patients. J Gastrointestin Liver Dis (2008) 0.83
Optimal technique for the removal of chest tubes after pulmonary resection. J Thorac Cardiovasc Surg (2013) 0.83
Tc-99m red blood cell bleeding scan in a pregnant woman presenting with hematemesis: a brief review of indications and guidelines for radionuclide scans during pregnancy. Clin Nucl Med (2011) 0.82
Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PET. J Nucl Med (2009) 0.82
Nuclear imaging of a pregnant patient: should we perform nuclear medicine procedures during pregnancy? Mol Imaging Radionucl Ther (2012) 0.82
Photodynamic laser therapy for lesions in the airway. Ann Thorac Surg (2010) 0.82
Is the "perfect Fontan" operation routinely achievable in the modern era? Cardiol Young (2008) 0.81
Predictors of survival and disease-free survival in patients with resected N1 non-small cell lung cancer. Ann Thorac Surg (2007) 0.81
Perspectives on robotic pulmonary resection: It's current and future status. Ann Cardiothorac Surg (2012) 0.81
Intercostal muscle flap to buttress the bronchus at risk and the thoracic esophageal-gastric anastomosis. Ann Thorac Surg (2005) 0.81
Positron emission tomography in patients with fibromyalgia syndrome and healthy controls. Arthritis Rheum (2004) 0.80
Restaging after neo-adjuvant chemoradiotherapy for N2 non-small cell lung cancer. Thorac Surg Clin (2008) 0.80
The role of integrated positron emission tomography-computerized tomography in evaluating and staging patients with non-small cell lung cancer. Semin Thorac Cardiovasc Surg (2007) 0.80
Survival after resection of synchronous non-small cell lung cancer. J Thorac Cardiovasc Surg (2011) 0.80
Does minimally invasive thoracic surgery warrant fast tracking of thoracic surgical patients? Thorac Surg Clin (2008) 0.80
The quantification of postoperative air leaks. Multimed Man Cardiothorac Surg (2009) 0.80